BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11141642)

  • 1. Systemic disorders associated with retinal vascular occlusion.
    Recchia FM; Brown GC
    Curr Opin Ophthalmol; 2000 Dec; 11(6):462-7. PubMed ID: 11141642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors for retinal occlusive diseases].
    Lang GE; Spraul CW
    Klin Monbl Augenheilkd; 1997 Oct; 211(4):217-26. PubMed ID: 9445908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia and retinal vascular occlusive disease.
    Battaglia Parodi M; Di Crecchio L
    Eur J Ophthalmol; 2003 Jun; 13(5):500; author reply 500-1. PubMed ID: 12841576
    [No Abstract]   [Full Text] [Related]  

  • 4. [Retinal vascular occlusions: diagnosis and management].
    Blaise P; Duchateau E; Duchesne B; Comhaire Y; Rakic JM
    Rev Med Interne; 2004 Dec; 25(12):881-90. PubMed ID: 15582168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal vascular occlusions in ocular Behçet disease - a comparative analysis.
    Ostrovsky M; Ramon D; Iriqat S; Shteiwi A; Sharon Y; Kramer M; Vishnevskia-Dai V; Sar S; Boulos Y; Tomkins-Netzer O; Lavee N; Ben-Arie-Weintrob Y; Pizem H; Hareuveni-Blum T; Schneck M; Gepstein R; Masarwa D; Nakhoul N; Bakshi E; Shulman S; Goldstein M; Anouk M; Rosenblatt A; Habot-Wilner Z
    Acta Ophthalmol; 2023 Sep; 101(6):619-626. PubMed ID: 36750991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia and retinal vascular occlusive disease.
    Abu El-Asrar AM; Abdel Gader AG; Al-Amro SA; Al-Attas OS
    Eur J Ophthalmol; 2002; 12(6):495-500. PubMed ID: 12510718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lupus anticoagulant and retinal vaso-occlusive disease.
    Fitzpatrick EP; Chesen N; Rahn EK
    Ann Ophthalmol; 1990 Apr; 22(4):148-52. PubMed ID: 2112354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalent misconceptions about acute retinal vascular occlusive disorders.
    Hayreh SS
    Prog Retin Eye Res; 2005 Jul; 24(4):493-519. PubMed ID: 15845346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and ocular complications.
    Templar H
    Nurs Stand; 2008 Oct 15-21; 23(6):59. PubMed ID: 18988569
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coagulative and fibrinolytic activities of the lacrimal fluid in health and in acute disorders of blood circulation in the eyes].
    Somov EE; Brzheskiĭ VV
    Vestn Oftalmol; 1992; 108(3):38-41. PubMed ID: 1481330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein (a): a risk factor for retinal vascular occlusion.
    Müller HM; Diekstall FF; Schmidt E; März W; Canzler H; Demeler U
    Ger J Ophthalmol; 1992; 1(5):338-41. PubMed ID: 1477637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined CRVO with CRAO in a patient with protein C deficiency.
    Desai S; Rai N; Kulkarni P; Natarajan S
    Retin Cases Brief Rep; 2014; 8(2):145-9. PubMed ID: 25372333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
    Lip PL; Blann AD; Jones AF; Lip GY
    Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular vascular thrombotic events: central retinal vein and central retinal artery occlusions.
    Glueck CJ; Ping Wang ; Hutchins R; Petersen MR; Golnik K
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):286-94. PubMed ID: 18160589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular diseases of the retina].
    Glacet-Bernard A; Meunier I
    Rev Prat; 1996 Sep; 46(14):1737-43. PubMed ID: 8949281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial dysplasminogenemia with central retinal vein and cilioretinal artery occlusion.
    Iijima H; Gohdo T; Tsukahara S
    Am J Ophthalmol; 1998 Aug; 126(2):312-4. PubMed ID: 9727530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular hypertonia disclosed by the association of central retinal vein and cilioretinal artery occlusions].
    Bordat B; Auch-Roy S; Boudet C
    Bull Soc Ophtalmol Fr; 1990 May; 90(5):521-4. PubMed ID: 2208518
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of hyperhomocystinemia in retinal vascular occlusive disease.
    Sottilotta G; Oriana V; Latella C; Luise F; Piromalli A; Ramirez F; Mammi C; Occhiuto A; Lombardo VT
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):104-7. PubMed ID: 17164500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cilioretinal artery occlusion and central retinal vein occlusion complicating hyperhomocysteinemia: a case report].
    Berkani Z; Kitouni Y; Belhadj A; Sifi K; Abbadi N; Bellatrache C; Hartani D; Kherroubi R
    J Fr Ophtalmol; 2013 Sep; 36(7):e119-27. PubMed ID: 23731792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic lysis therapy in retinal vascular occlusions].
    Hattenbach LO
    Ophthalmologe; 1998 Aug; 95(8):568-75. PubMed ID: 9782735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.